Leflunomide: Traditional immunosuppressant with concurrent antiviral effects

Int J Rheum Dis. 2023 Feb;26(2):195-209. doi: 10.1111/1756-185X.14491. Epub 2022 Nov 13.

Abstract

Leflunomide is a classic disease-modifying anti-rheumatic drug that is widely used to treat autoimmune diseases. Studies also show its antiviral effects in in vitro and/or in vivo experiments. Considering glucocorticoids, immunosuppressants and newly emerged antibodies commonly used in autoimmune diseases and autoinflammatory disorders bring risk of infection such as viral infection, leflunomide with combination of anti-viral and immunosuppressive features to maintain the balance between infection and anti-inflammation are attractive. Here we summarize the actions and mechanisms of leflunomide in immunoregulatory and antiviral effects.

Keywords: anti-viral effect; autoinflammation; immunosuppressant; leflunomide.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / adverse effects
  • Autoimmune Diseases*
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Isoxazoles / adverse effects
  • Leflunomide / therapeutic use

Substances

  • Leflunomide
  • Immunosuppressive Agents
  • Antiviral Agents
  • Isoxazoles